or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    GH B Guardant Health, Inc. 0.98
    PRAX C Praxis Precision Medicines, Inc. -0.84
    WGS C GeneDx Holdings Corp. 3.88
    EXAI D Exscientia Limited 0.00
    CRSP D CRISPR Therapeutics AG -2.05
    AVTX D Avalo Therapeutics, Inc. -11.47
    STOK F Stoke Therapeutics, Inc. -0.35
    IDYA F IDEAYA Biosciences, Inc. 4.15
    ORIC F Oric Pharmaceuticals, Inc. 4.35
    NTLA F Intellia Therapeutics, Inc. 5.18
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Medicine Biology Biopharmaceutical Biotechnology Systems Biology Biomarkers CRISPR Cancer Cas9 Clinical Medicine Disease Drug Discovery Emerging Technologies Evidence Based Medicine Genetics Genome Editing Immune System Molecular Biology Oncology Targeted Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.23
    LRNZ A TrueMark Technology, AI & Deep Learning ETF 0.8
    CANC D Tema Oncology ETF 0.69
    ARKG F ARK Genomic Revolution Multi-Sector ETF 0.64
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 0.57
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare CANC to ARKG Compare CNCR to ARKG Compare LRNZ to CANC

        Precision Medicine Stocks Recent News

        Date Stock Title
        Nov 21 CRSP Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
        Nov 20 GH Guardant Health Stock Sees RS Rating Jump To 83
        Nov 20 GH Guardant Health: Focused On Future Growth, Hold
        Nov 20 STOK Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
        Nov 20 CRSP CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?
        Nov 20 EXAI Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
        Nov 20 CRSP CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 WGS GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
        Nov 19 NTLA Intellia Therapeutics Announces Promising CRISPR Therapy Results
        Nov 19 NTLA ReCode to secure funds for cystic fibrosis gene correction treatments
        Nov 19 NTLA Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
        Nov 19 NTLA Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)
        Nov 18 NTLA Intellia’s gene editing therapy shows early potential in rare heart condition
        Nov 18 WGS GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
        Nov 18 NTLA CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
        Nov 18 CRSP CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 17 CRSP CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024
        Nov 16 NTLA Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Biotechnology Cancer Cancer Therapies Disease Genomics Proteomics Solid Tumors Advanced Solid Tumors Artificial Intelligence Bioinformatics Biology Biomarkers CRISPR Cancer Cell Cancer Treatment Cell Biology Checkpoint Inhibitor Clinical Medicine Drug Delivery Drug Discovery
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags